Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Latest filing published 23 Mar 2026 for Orasure Technologies INC, €82k.
Filing timeline
BuySaleManner Carrie Eglinton
Insider track record
Disclosed buys
5
Disclosed sells
2
Signal history
Closed purchases
Market purchases
5
Positive at T+90
60%
Median T+90
+6.3%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +35.9%Entry US$3.06 · Close at T+90 US$4.16
- +39.9%Entry US$2.98 · Close at T+90 US$4.17
- -10.7%Entry US$3.37 · Close at T+365 US$3.01
- -14.9%Entry US$3.48 · Close at T+365 US$2.96
- +7.2%Entry US$164.84 · Close at T+365 US$176.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Manner Carrie Eglinton: trading record in brief
Manner Carrie Eglinton made 5 purchases worth EUR 570,815, median EUR 96,225, including EUR 235,850 on February 27, 2025 and EUR 96,225 the next day at Orasure Technologies Inc, and EUR 99,721 on March 16, 2022 at Repligen Corp. Purchases make up 71% of open-market trades. Two sales, of EUR 258,733 and EUR 254,045, fall on the same day, April 27, 2020, at Quest Diagnostics Inc, for EUR 512,778 in total.
The 55 filings, published from February 23, 2017 to March 23, 2026, split between Quest (29, as SVP, Advanced Diagnostics), Orasure (20, as President & CEO) and Repligen (6, as Director). The record holds 48 share grants, with no option exercise. The year 2022 is the busiest, with 10 filings, ahead of 2020 (9) and 2025 (8). Six filings fall in the last twelve months, 2 of them purchases.
They appear a median of 2 days after the trade. At Orasure, Kenneth J. McGrath has 4 open-market trades within 30 days of those of Eglinton, John P. Kenny, Lelio Marmora and Nancy J. Gagliano 2 each, in the same direction.
Companies and markets linked to Manner Carrie Eglinton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations55 total
32,300 shares@ US$2.92872.1% of flowCommon StockSEC:0001470831-26-000310:0
Canonical exit: 18 Jun 2026 (T+90)
22,022 shares@ US$2.99851.5% of flowCommon StockSEC:0001470831-26-000281:0
Canonical exit: 11 Jun 2026 (T+90)
355,464 shares0Common StockSEC:0001470831-26-000241:3
56,116 shares@ US$3.041.6% of flowCommon StockSEC:0001470831-26-000241:1
122,655 shares@ US$3.043.5% of flowCommon StockSEC:0001470831-26-000241:2
129,032 shares0Common StockSEC:0001470831-26-000241:0
146,000 shares@ US$2.904.1% of flowCommon StockSEC:0001062993-25-011071:1
47,249 shares@ US$2.901.3% of flowCommon StockSEC:0001062993-25-011071:2
335,710 shares0Common StockSEC:0001062993-25-011071:0
973 shares0Common StockSEC:0000950170-25-074747:0
62,382 shares@ US$3.632.4% of flowCommon StockSEC:0001062993-25-004316:1
462,414 shares0Common StockSEC:0001062993-25-004316:0
28,670 shares@ US$3.48894.2% of flowCommon StockSEC:0001062993-25-004056:0
Canonical exit: 29 May 2025 (T+90)
78,625 shares@ US$3.146310.3% of flowCommon StockSEC:0001062993-25-003843:0
Canonical exit: 28 May 2025 (T+90)
401,618 shares@ US$4.6574.9% of flowCommon StockSEC:0001062993-24-012025:0
701 shares0Common StockSEC:0000950170-24-062601:0
29,647 shares@ US$7.192.2% of flowCommon StockSEC:0001062993-24-005509:1
260,688 shares0Common StockSEC:0001062993-24-005509:0
47,211 shares@ US$5.4810.6% of flowCommon StockSEC:0001062993-23-013045:0
686 shares0Common StockSEC:0000899243-23-013670:0
258,065 shares0Common StockSEC:0001062993-23-005964:0
625 shares@ US$175.02100.0% of flowCommon StockSEC:0000899243-22-038565:0
Canonical exit: 14 Jun 2022 (T+90)
325,932 shares@ US$4.9116.5% of flowCommon StockSEC:0001062993-22-014386:1
814,830 shares@ US$4.90996.4% of flowCommon StockSEC:0001062993-22-014386:0
1,024 shares0Common StockSEC:0000899243-22-020272:0
25 of 55 declarations
